DELRAY BEACH, FL / ACCESS Newswire / April 23, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company") is developing ...

Iovance's Amtagvi is the first TIL therapy approved by the U.S. Food and Drug Administration (FDA). Its first approved ...

Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the succession of ...

South Korea-based biotech firms 1ST Biotherapeutics and LigaChem Biosciences (Kosdaq: 141080) have entered a strategic ...

Safi to bulk manufacture Children's Hospital of Philadelphia's iPSC-derived RBCs with rare antigen profiles as diagnostic tools for alloim ...

Bridge Biotherapeutics, which is developing a new drug for idiopathic ... and is being developed as a first-in-class treatment that alleviates inflammation and fibrosis. Study links digital device use ...

the co-founders of Creative BioTherapeutics LLC (CBT). Their work, founded on Dr. Don's decades-long research, has brought to light an innovative solution: CBT300, a first-in-class biologic ...

Given the types of proteins induced in the TME ... of bispecific candidates using the FHAB platform. About Sonnet BioTherapeutics Holdings, Inc. Sonnet is an oncology-focused biotechnology ...

Additionally, a copy of each poster will be available on the Publications page of the Bolt Biotherapeutics website at the start of each poster session. Title: BDC-3042, a first-in-class Dectin-2 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.